Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
cerebellar dysfunction with variable cognitive and behavioral abnormalities
Mode Of Inheritance:
Autosomal dominant
Evaluated Date:
05/16/2023
Evidence/Notes:

CAMTA1 was first reported in relation to cerebellar dysfunction with variable cognitive & behavioral abnormalities in 2011 (Mikhail et.al, PMID: 22031302). Probands are characterized by cerebellar ataxia, global developmental delay, speech delay, hypotonia, dysmorphism, behavioral abnormalities (ADHD, OCD, autistic features) and movement disorders such as tremors and myotonic dystonia. Less common phenotypes include epilepsy, GERD, velopharyngeal insufficiency, constipation, strabismus & nystagmus. Inheritance of variants is primarily de novo. Twenty one variants (missense, nonsense, frameshift, CNV: deletions & duplications) in 22 probands in 7 publications (PMIDs: 22031302, 33131045, 33677721, 30838254, 22693284, 24738973, 32157189) have been included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached.

The mechanism of pathogenicity appears to be haploinsufficiency, but a dominant negative mechanism could not be ruled out (PMID:22693284).

This gene-disease relationship is also supported by experimental evidence..Both constitutive deletion of Camta1 and conditional deletion in the G nervous system causes severe ataxia with Purkinje cell degeneration and cerebellar atrophy in mice, partially recapitulating the consequences of haploinsufficiency of the human CAMTA1 locus (PMID: 25049392).

In summary, there is definitive evidence to support the relationship between CAMTA1 and cerebellar dysfunction with variable cognitive and behavioral abnormalities. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on May 16, 2023 (SOP 9).

PubMed IDs:
22031302 22693284 24738973 25049392 30838254 32157189 33131045 33677721
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.